Camilla S. Graham, MD, MPH is the Co-Director of the Viral Hepatitis Center in the Division of Infectious Disease at Beth Israel Deaconess Medical Center and an Assistant Professor of Medicine at Harvard Medical School in Boston, Massachusetts. She is also the Vice President, Medical Affairs at PureTech health where her team is developing the first new therapy for the rare disease idiopathic pulmonary fibrosis in ten years. Camila has previously served as the Vice President of Corporate and Medical Affairs at Trek Therapeutics, PBC and Head of Global Medical Affairs at Vertex Pharmaceuticals. As someone who straddles academic medicine and the pharmaceutical industry, Dr. Graham has been an advisor to public and private payers in the US, government agencies, and global organizations such as the World Health Organization and the Foundation for Innovative New Diagnostics. Her expertise includes systems improvements to implement medical guidelines, workforce capacity building, and pricing and access to therapeutics.